Lee Ainslie Thermo Fisher Scientific Inc. Transaction History

Maverick Capital LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$528.82 - $599.43 $408,249 - $462,759	-772 Reduced 50.76%	749 $435,000
Q4 2023 Feb 14, 2024	BUY	$431.41 - $532.94 $318,380 - $393,309	738 Added 94.25%	1,521 $807,000
Q3 2023 Nov 14, 2023	BUY	$498.29 - $574.41 $390,161 - $449,763	783 New	783 $396,000
Q3 2021 Nov 15, 2021	SELL	$509.53 - $609.78 $446,348 - $534,167	-876 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$441.0 - $508.24 $669,879 - $772,016	-1,519 Reduced 63.42%	876 $442,000
Q1 2021 May 17, 2021	BUY	$439.85 - $518.83 $570,485 - $672,922	1,297 Added 118.12%	2,395 $1.09 Million
Q4 2020 Feb 16, 2021	BUY	$435.06 - $527.66 $477,695 - $579,370	1,098 New	1,098 $511,000
Q2 2020 Aug 14, 2020	SELL	$275.2 - $362.34 $60,819 - $80,077	-221 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$255.3 - $340.05 $56,421 - $75,151	221 New	221 $63,000
Q4 2019 Feb 14, 2020	SELL	$271.93 - $328.04 $3.29 Million - $3.96 Million	-12,086 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$268.46 - $305.43 $3.24 Million - $3.69 Million	12,086 New	12,086 $3.52 Million
Q2 2019 Aug 14, 2019	SELL	$257.51 - $295.55 $6.79 Million - $7.79 Million	-26,370 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$212.17 - $273.72 $922,939 - $1.19 Million	4,350 Added 19.75%	26,370 $7.22 Million
Q4 2018 Feb 14, 2019	BUY	$208.47 - $251.98 $2.23 Million - $2.69 Million	10,690 Added 94.35%	22,020 $4.93 Million
Q3 2018 Nov 14, 2018	BUY	$205.57 - $244.32 $2.33 Million - $2.77 Million	11,330 New	11,330 $2.77 Million

2,809

332M

2.37M

2.75M

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $225B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.